| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.06B | +36.3% |
| Cost of Revenue | $755.7M | +25.7% |
| Gross Profit | $2.30B | +40.2% |
| R&D Expense | $768.5M | +26.3% |
| SG&A Expense | $392.8M | +23.8% |
| Operating Income | -$2.0M | +99.0% |
| Interest Expense | $25.8M | +1.7% |
| Pre-tax Income | $122.8M | +176.8% |
| Income Tax | $32.2M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.38B | +37.5% |
| Short-term Investments | $99.6M | -60.2% |
| Accounts Receivable | $853.1M | +36.2% |
| Current Assets | $4.76B | +30.7% |
| Total Assets | $6.65B | +32.2% |
| Current Liabilities | $2.70B | +27.9% |
| Long-term Debt | $742.5M | +0.2% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.17B | +23.9% |
| Capital Expenditures | $176.5M | -24.9% |
| Investing Cash Flow | -$340.6M | +38.8% |
| Financing Cash Flow | $93.2M | +20.3% |
| Free Cash Flow | $989.7M | +40.2% |
| +43.9% |
| Net Income | $89.3M | +148.7% |
| EPS (Basic) | $0.37 | +146.8% |
| EPS (Diluted) | $0.37 | +146.8% |
| Total Liabilities |
| $4.31B |
| +21.8% |
| Stockholders' Equity | $2.30B | +57.4% |